Tumor-Induced Erythroid Precursor-Differentiated Myeloid Cells Mediate Immunosuppression and Curtail Anti-PD-1/PD-L1 Treatment Efficacy

Using lineage tracking in cancer patients and tumor-bearing mice, the authors demonstrated that erythroid progenitor cells lost their developmental potential and switched to the myeloid lineage.